Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Alexander Disease

Neurological & Neuromuscular

Alexander Disease Clinical Trials and Treatments

Also called AxD, GFAP-related leukodystrophy, fibrinoid gliosis

Alexander disease (AxD) is a rare autosomal dominant leukodystrophy caused by mutations in the GFAP gene encoding glial fibrillary acidic protein; most cases, especially in young children, come from a new mutation rather than from a parent. GFAP is a major structural component of astrocyte intermediate filaments. These mutations lead to abnormal accumulation of phosphorylated GFAP and other proteins forming characteristic Rosenthal fibers—hyaline inclusions within astrocytes—and result in severe astrocyte dysfunction.

In plain words, Alexander disease is a rare genetic condition where support cells in the brain build up clumps of abnormal protein. Over time this damages the brain and spinal cord and can affect learning, movement, coordination and speech.

Get an email when new Alexander Disease trials open or the FDA decides. Get alerts

Alexander Disease

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 2 studies with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines1

Zanvastro

Alexander Disease has 1 FDA-approved medicine, 2 open or active clinical trials (2 recruiting), and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

Latest for Alexander Disease

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Alexander Disease

The disease causes progressive neurodegeneration affecting both white matter and gray matter structures with profound impact on motor, cognitive, and behavioral functions. The infantile form is the most severe, typically presenting before age 2 with developmental delay, seizures, and rapid progressive neurological deterioration. Megalencephaly (abnormally enlarged brain) is characteristic and may be present at birth.

Keep reading about Alexander Disease

The juvenile form has onset between ages 2-12 with more gradual progression and different clinical features. The adult form has the slowest progression and sometimes presents with relatively mild focal symptoms. MRI characteristically shows periventricular white matter signal changes, Rosenthal fiber accumulation predominantly in frontal regions, and progressive atrophy. The pattern of white matter involvement may help distinguish it from other leukodystrophies.

What are the symptoms of Alexander Disease?

These are common symptoms of Alexander Disease, and how strong they are varies from person to person.

  • Progressive developmental delay and cognitive decline
  • Spasticity and hyperreflexia
  • Ataxia and coordination problems
  • Seizures
  • Megalencephaly in infantile form
  • Bulbar dysfunction and speech difficulties

Who gets Alexander Disease?

Alexander disease has three clinical forms with distinct age presentations: infantile form with onset before age 2 (most common and severe), juvenile form with onset ages 2-12 (intermediate severity), and adult form with onset after age 12 (slowest progression).

The condition affects males and females equally. Autosomal dominant inheritance means approximately 50% of offspring of affected parents inherit mutations, though de novo mutations account for a significant proportion of cases. Penetrance appears to be high.

Next steps: find trials you might fitsee approved treatmentsget help payingget alerts

Which medicines are FDA-approved for Alexander Disease?

There is currently 1 FDA-approved medication for Alexander Disease.

zilganersen
Ionis Pharmaceuticals
Search

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for Alexander Disease treatment

Charity funds and drugmaker programs for Alexander Disease, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Charity funds
  • From a charity · United Leukodystrophy Foundation
    Hultman Memorial Fund fund
    Open

    Pays for: Expenses directly related to the affected family member, based on demonstrated hardship (per 12 months), up to $500 per year.

    The foundation says: “Applications are reviewed on a rolling basis as funding is available.”
Status as each foundation showed it on November 16, 2026.
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Every program and fund for Alexander Disease, by insurance →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Alexander Disease

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Alexander Disease resources

Reputable organizations and medical references for learning more about Alexander Disease, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Alexander Disease

Use this Alexander Disease clinical trial finder to see the 2 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. None of them test a treatment; they follow patients over time. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

2 active trials worldwide
Filter:
Sort:
RecruitingPatient registry covering many conditionsRecently updatedNCT03047369

The Myelin Disorders Biorepository Project

Sponsor: Children's Hospital of Philadelphia · Biogen + 5 more

The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, havin...

Ages not specified
Started Dec 2016Updated 6 days agoEst. Dec 2030 (~4 years)
RecruitingObservational study, no treatment givenNo updates in a whileNCT02714764

Evaluation of Outcome Metrics in Alexander Disease

Sponsor: Children's Hospital of Philadelphia · Ionis Pharmaceuticals, Inc.

The purpose of this study is to define the natural history of Alexander Disease, a leukodystrophy that causes neurological dysfunction. Investigators will obtain clinical outcome assessments to measure how the disease affects a patient's gross motor, fine motor, speech and langua...

Ages not specified1 location
Started Jan 2016Updated 10 months agoEst. Dec 2030 (~4y 1m)
Find Alexander Disease trials near you, ranked by distance →
Active trial locations22 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+14 more

Trial Pipeline

Jan 2021 to Dec 2030
2021
2023
2025
2027
2029
now
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Alexander Disease trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run an Alexander Disease foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Alexander Disease patient communities

Facebook groups, Reddit communities and YouTube channels where Alexander Disease patients, caregivers and advocacy groups talk.

Companies developing Alexander Disease treatments

Drugmakers that list Alexander Disease in their rare disease portfolio, 1 in all.

Questions people ask about Alexander Disease